Developer docs
API playgroundTry for free, no card

Search company profiles

Osmind

Full company profile

uuid00008r2

Namestring
Osmind
Legal namestring
Osmind, Inc.
Websiteurl
osmind.org
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Osmind, Inc. is a San Francisco-based Public Benefit Corporation founded in 2020 by Lucia Huang (CEO) and Jimmy Qian (President). The company sells an AI-powered, psychiatry-tailored electronic health record platform called Osmind One, purpose-built for interventional psychiatry workflows covering TMS, ketamine, esketamine (SPRAVATO), psychedelic-assisted therapy, and in-office infusion services. The core platform bundles charting, scheduling, e-prescribing with PDMP access, lab ordering, HIPAA-compliant telehealth, 50+ validated clinical scales, automated REMS submission (including direct J&J SPRAVATO integration), and measurement-based outcomes tracking. Layered on Osmind One are the Osmind Care Network (credentialing and referral product), Osmind 360 (managed revenue cycle management and in-office infusion suite support), and Osmind Agent, a multimodal AI agent combining vitals, audio, video, and smartphone passive sensing to automate clinical and administrative workflows. Adjacent sub-brands include the Psychiatry Collective clinician community, the Psychiatry Tomorrow podcast, and Osmind Life Sciences, which monetizes the network's real-world data for pharma, biotech, and medical device sponsors.

Osmind generates revenue through a multi-stream model: per-clinician EHR subscription ($249/month plus add-ons), usage-based revenue cycle management (% of collections with $500/month minimum per clinic), usage-based in-office infusion suite support (Osmind 360, % of collections with $15,000/month minimum), one-time implementation and credentialing fees, and B2B data monetization through life sciences partnerships. The go-to-market is sales-led via direct sales, inside sales, and website-driven demos to independent interventional psychiatry practices, complemented by a community-led motion (Psychiatry Collective, Psychiatry Tomorrow podcast) and a GPO distribution partnership with CareNet GPO. Life Sciences Solutions are sold via enterprise B2B sales to pharma/biotech/medical device sponsors.

As of mid-2026, Osmind reports 1,000+ practices, 2,500+ clinicians, 1M+ treatments delivered, 3.6M+ outcomes measured, and 1.6B+ structured clinical variables across its network. The company has raised approximately $57M in venture funding across a Series A led by Future Ventures (July 2021, $15M) and a Series B led by DFJ Growth (May 2022, $40M), with backing from General Catalyst, Tiger Global, Susa Ventures, and Y Combinator. Key life sciences partnerships include Compass Pathways, Cybin, Otsuka Precision Health, NRx Pharmaceuticals, UBC, LivaNova, and Bendable Therapy; the platform has supported FDA Type C meetings and NDA-grade real-world evidence delivery.

Short descriptiontext

Osmind is a San Francisco-based Public Benefit Corporation that sells an AI-powered, psychiatry-tailored EHR (Osmind One) plus revenue cycle, credentialing, and in-office infusion suite services to 1,000+ independent interventional psychiatry practices in the U.S., and monetizes its real-world clinical dataset with life sciences sponsors.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
interventional psychiatry software, psychiatry electronic health records, medical billing services, real-world evidence platform, practice management software
Industry1 code
PRIMARYHLALAEAB
Psychiatry & Medication Management Platforms
Healthcare & Life Sciences/Telehealth Platforms/Behavioral & Mental Health Teletherapy Platforms
NAICS code1 code
  • Computer Systems Design and Related Services5415
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Mental Health EHR Software
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model6 records
1Osmind One EHR subscription
TypeSubscription Recurring
Description

Per-clinician monthly subscription for the AI-powered psychiatry EHR; includes e-prescribing ($49/mo per clinician) and per-submission SPRAVATO REMS fees ($4 per submission). Recurring subscription.

2Osmind Care Network (RCM)
TypeUsage Based
Description

Revenue cycle management service billed as a percentage of collections with a $500/month minimum per clinic; includes medical billing, credentialing, and prior authorization. Transaction/usage-based.

3Osmind 360 (in-office drug infusion suite)
TypeUsage Based
Description

In-office infusion suite solution billed as a percentage of collections with a $15,000 monthly minimum; supports ketamine/esketamine and similar in-clinic infusions. Usage-based / take-rate style.

4Life Sciences Solutions
TypeData Monetisation
Description

B2B data, real-world evidence, and commercial readiness offerings sold to pharma, biotech, and medical device companies (e.g., partnerships with Compass Pathways, Cybin, Otsuka Precision Health, NRx Pharmaceuticals, UBC). B2B data monetisation and professional services.

5Implementation, credentialing, and processing fees
TypeProfessional Services
Description

One-time implementation fees ($2,000–$5,000), per-payer-per-clinician credentialing fees ($200), and credit card processing at 2.9% + $0.30. Professional services + transaction fees.

6Buy-and-bill drug margin
TypeTransaction Fee
Description

Margin on buy-and-bill drug purchases (e.g., ketamine, esketamine) facilitated through Osmind 360 and integrated discount programs. Hardware/drug resale margin (treated as usage-based professional services line).

Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Pricing details6 tiers
1Osmind One EHR
ModelPer seatBilling cadenceMonthly
Notes

$249/month per clinician for the AI-powered psychiatry EHR.

2E-prescribing add-on
ModelPer seatBilling cadenceMonthly
Notes

$49/month per clinician for e-prescribing.

3SPRAVATO REMS submission
ModelUsage-basedBilling cadencePay-as-you-go
Notes

$4 per submission for SPRAVATO REMS.

4Osmind Care Network (RCM)
ModelUsage-basedBilling cadenceMonthly
Notes

Percentage of collections, with a $500/month minimum per clinic; includes medical billing, credentialing, and prior authorization.

5Osmind 360 (in-office infusion suite)
ModelUsage-basedBilling cadenceMonthly
Notes

Percentage of collections with a $15,000 monthly minimum; supports in-office ketamine/esketamine infusion operations.

6One-time fees and processing
ModelOtherBilling cadencePay-as-you-go
Notes

Implementation fees of $2,000–$5,000; credentialing fees of $200 per payer per clinician; credit card processing at 2.9% + $0.30.

GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 5 records shown
1Osmind One
Description

Psychiatry-tailored EHR software (formerly 'Original Osmind One') for practices billing cash or insurance on their own. Priced at $249/month per clinician.

osmind.org
+4 more records
Core offering1 text field

Osmind provides an AI-powered, psychiatry-tailored electronic health record (EHR) platform — Osmind One — purpose-built for interventional psychiatry practices delivering treatments such as TMS, ketamine, esketamine (SPRAVATO), and psychedelic-assisted therapies. Layered on Osmind One are Osmind Care Network (credentialing and payer-contract access), Osmind 360 (managed revenue cycle management and in-office infusion suite support), the Osmind Agent multimodal AI module, and a Life Sciences Solutions business that sells regulatory-grade real-world evidence derived from the network's 1.6B+ structured clinical variables to pharma, biotech, and medical device sponsors.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 9 values shown
  • 1M+ treatments delivered
+8 more records
Product overview1 text field

Osmind operates a platform-plus-modules architecture anchored by its core psychiatric EHR, Osmind One, which unifies charting, scheduling, e-prescribing with PDMP access, lab ordering, telehealth, AI-powered workflows, and reporting for interventional psychiatry practices. Layered on top of Osmind One are the Osmind Agent autonomous AI module (multimodal sensing and workflow automation), the Osmind Care Network credentialing/referral product, and the Osmind 360 managed revenue cycle / billing service. Adjacent offerings include the Life Sciences real-world evidence platform (used with partners such as Compass Pathways, Cybin, and NRx Pharma) and content/community sub-brands (Psychiatry Collective and the Psychiatry Tomorrow Podcast) that support the same psychiatric practices served by the core platform.

Product and service5 records
1Osmind One
CategoryPsychiatry EHR / Practice Management Platform
Description

Osmind One is the company's flagship cloud-based electronic health record and practice management platform built specifically for interventional psychiatry practices. It bundles charting, scheduling, e-prescribing with PDMP access, lab ordering, HIPAA-compliant telehealth, AI-powered workflows, and reporting into a single product priced at $249/month per clinician.

2Osmind Care Network
CategoryCredentialing / Network Service
Description

Osmind Care Network is a curated network of interventional psychiatry practices combined with a credentialing, payer-contract, and implementation service designed to launch and scale insurance, SPRAVATO, TMS, and VNS programs for psychiatry practices.

3Osmind 360
CategoryRevenue Cycle Management / Billing Services
Description

Osmind 360 is a managed billing, revenue cycle management, and in-office infusion suite service for psychiatric practices ready to scale, integrating directly with Osmind One to provide credentialing, insurance verification, claims submission, denial management, and buy-and-bill drug administration.

4Osmind Agent
CategoryAI Workflow Automation Module
Description

Osmind Agent is a multimodal AI agent add-on module that combines continuous vitals monitoring, audio, video, and smartphone passive sensing to autonomously execute multi-step clinical and administrative workflows such as prior authorization submission and patient context surfacing.

5Osmind Life Sciences Solutions
CategoryReal-World Evidence / Life Sciences Data Services
Description

Osmind Life Sciences Solutions is a B2B offering that leverages the Osmind One dataset (70,000+ patient dataset, 1.6B+ structured clinical variables) to deliver regulatory-grade real-world evidence for psychiatric drug development, supporting FDA submissions, Type C meetings, and commercial readiness partnerships.

Scale indicator12 records

Each record includes

Type, Value, Description, Source

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

TherapyNotes is a leading practice management and EHR platform built specifically for behavioral health providers, including psychiatrists, psychologists, and therapists. Like Osmind, it offers scheduling, documentation, billing, and a telehealth add-on, but serves a broader behavioral health base rather than interventional psychiatry specifically.

TypeBroad incumbent
Description

athenahealth is a large, established EHR and practice management vendor serving ambulatory practices across many specialties. It is a broad incumbent that competes with Osmind One in the general EHR/practice management category, but does not specialize in interventional psychiatry workflows like REMS, buy-and-bill, or ketamine/SPRAVATO protocols.

TypeDirect peer
Description

Valant is a behavioral health-specific EHR and practice management platform serving psychiatry and therapy practices. It is the most direct comparator to Osmind One in the psychiatric EHR category, with comparable charting, scheduling, e-prescribing, and billing workflows targeted at the same independent practice customer base.

TypeBroad incumbent
Description

Lyra Health is a large mental health benefits platform serving employers with EAP, therapy, coaching, and psychiatric medication services. It overlaps with Osmind Care Network on the network/credentialing concept and competes for the same employer-sponsored mental health dollar, though Lyra delivers care directly while Osmind enables practices.

TypeDirect peer
Description

SimplePractice is an all-in-one practice management platform for health and wellness practitioners, including mental health providers. It overlaps with Osmind One on charting, scheduling, billing, and telehealth, but is positioned for solo and small group practices across many specialties rather than interventional psychiatry specifically.

TypeRegional player
Description

Cerebral is a direct-to-consumer mental health platform offering telehealth psychiatry and therapy services, including medication management. While Cerebral delivers care (rather than selling software), it represents the vertically-integrated care model that Osmind could pursue and competes for the same interventional psychiatry patient population in the US.

TypeBroad incumbent
Description

DrChrono, part of EverCommerce's healthcare vertical, is a cloud-based EHR and medical billing platform serving ambulatory practices. It overlaps with Osmind on EHR and RCM but lacks the interventional psychiatry specialization, making it a partial competitor for general psychiatry practices.

TypeRegional player
Description

Talkiatry is a telepsychiatry practice group employing psychiatrists and delivering care directly to patients. It competes with Osmind-served independent practices for psychiatrists and patients, and represents an alternative vertically-integrated model for in-network psychiatric care in the US.

TypeBroad incumbent
Description

Tebra is a practice management, EHR, and patient experience platform serving independent practices. Like Osmind, it bundles charting, scheduling, billing, and telehealth, but does not have purpose-built interventional psychiatry workflows and is positioned for general medical practices.

TypeEmerging player
Description

Headway is a managed network platform that connects mental health patients to in-network therapists and psychiatrists, handling credentialing, insurance billing, and payer contracts. It competes with Osmind Care Network's credentialing and payer contract value proposition, though Headway focuses on therapy rather than interventional psychiatry.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration11 records

Each record includes

Title, Type, Description, Source

AI capability12 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors16 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Osmind

Mental Health EHR Softwareosmind.org

Osmind is a San Francisco-based Public Benefit Corporation that sells an AI-powered, psychiatry-tailored EHR (Osmind One) plus revenue cycle, credentialing, and in-office infusion suite services to 1,000+ independent interventional psychiatry practices in the U.S., and monetizes its real-world clinical dataset with life sciences sponsors.

What Osmind does

Osmind, Inc. is a San Francisco-based Public Benefit Corporation founded in 2020 by Lucia Huang (CEO) and Jimmy Qian (President). The company sells an AI-powered, psychiatry-tailored electronic health record platform called Osmind One, purpose-built for interventional psychiatry workflows covering TMS, ketamine, esketamine (SPRAVATO), psychedelic-assisted therapy, and in-office infusion services. The core platform bundles charting, scheduling, e-prescribing with PDMP access, lab ordering, HIPAA-compliant telehealth, 50+ validated clinical scales, automated REMS submission (including direct J&J SPRAVATO integration), and measurement-based outcomes tracking. Layered on Osmind One are the Osmind Care Network (credentialing and referral product), Osmind 360 (managed revenue cycle management and in-office infusion suite support), and Osmind Agent, a multimodal AI agent combining vitals, audio, video, and smartphone passive sensing to automate clinical and administrative workflows. Adjacent sub-brands include the Psychiatry Collective clinician community, the Psychiatry Tomorrow podcast, and Osmind Life Sciences, which monetizes the network's real-world data for pharma, biotech, and medical device sponsors.

Osmind generates revenue through a multi-stream model: per-clinician EHR subscription ($249/month plus add-ons), usage-based revenue cycle management (% of collections with $500/month minimum per clinic), usage-based in-office infusion suite support (Osmind 360, % of collections with $15,000/month minimum), one-time implementation and credentialing fees, and B2B data monetization through life sciences partnerships. The go-to-market is sales-led via direct sales, inside sales, and website-driven demos to independent interventional psychiatry practices, complemented by a community-led motion (Psychiatry Collective, Psychiatry Tomorrow podcast) and a GPO distribution partnership with CareNet GPO. Life Sciences Solutions are sold via enterprise B2B sales to pharma/biotech/medical device sponsors.

As of mid-2026, Osmind reports 1,000+ practices, 2,500+ clinicians, 1M+ treatments delivered, 3.6M+ outcomes measured, and 1.6B+ structured clinical variables across its network. The company has raised approximately $57M in venture funding across a Series A led by Future Ventures (July 2021, $15M) and a Series B led by DFJ Growth (May 2022, $40M), with backing from General Catalyst, Tiger Global, Susa Ventures, and Y Combinator. Key life sciences partnerships include Compass Pathways, Cybin, Otsuka Precision Health, NRx Pharmaceuticals, UBC, LivaNova, and Bendable Therapy; the platform has supported FDA Type C meetings and NDA-grade real-world evidence delivery.

Osmind firmographics

Firmographics
Name
Osmind
Legal name
Osmind, Inc.
Website
https://osmind.org
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
51–100 employees
Short description
Osmind is a San Francisco-based Public Benefit Corporation that sells an AI-powered, psychiatry-tailored EHR (Osmind One) plus revenue cycle, credentialing, and in-office infusion suite services to 1,000+ independent interventional psychiatry practices in the U.S., and monetizes its real-world clinical dataset with life sciences sponsors.
Ownership category
akta.pro rank

Osmind industry classification

Industry
Product category
Mental Health EHR Software
NAICS
Computer Systems Design and Related Services (5415)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLALAEAB
Psychiatry & Medication Management Platforms
Healthcare & Life Sciences/Telehealth Platforms/Behavioral & Mental Health Teletherapy Platforms

Keywords

  • Interventional psychiatry software
  • Psychiatry electronic health records
  • Medical billing services
  • Real-world evidence platform
  • Practice management software

Where Osmind is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Osmind business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Osmind One EHR subscription: Per-clinician monthly subscription for the AI-powered psychiatry EHR; includes e-prescribing ($49/mo per clinician) and per-submission SPRAVATO REMS fees ($4 per submission). Recurring subscription.
  2. Osmind Care Network (RCM): Revenue cycle management service billed as a percentage of collections with a $500/month minimum per clinic; includes medical billing, credentialing, and prior authorization. Transaction/usage-based.
  3. Osmind 360 (in-office drug infusion suite): In-office infusion suite solution billed as a percentage of collections with a $15,000 monthly minimum; supports ketamine/esketamine and similar in-clinic infusions. Usage-based / take-rate style.
  4. Life Sciences Solutions: B2B data, real-world evidence, and commercial readiness offerings sold to pharma, biotech, and medical device companies (e.g., partnerships with Compass Pathways, Cybin, Otsuka Precision Health, NRx Pharmaceuticals, UBC). B2B data monetisation and professional services.
  5. Implementation, credentialing, and processing fees: One-time implementation fees ($2,000–$5,000), per-payer-per-clinician credentialing fees ($200), and credit card processing at 2.9% + $0.30. Professional services + transaction fees.
  6. Buy-and-bill drug margin: Margin on buy-and-bill drug purchases (e.g., ketamine, esketamine) facilitated through Osmind 360 and integrated discount programs. Hardware/drug resale margin (treated as usage-based professional services line).

Pricing tiers

ModelBillingPrice
Per seatMonthlyOsmind One EHR
Per seatMonthlyE-prescribing add-on
Usage-basedPay-as-you-goSPRAVATO REMS submission
Usage-basedMonthlyOsmind Care Network (RCM)
Usage-basedMonthlyOsmind 360 (in-office infusion suite)
OtherPay-as-you-goOne-time fees and processing

Go-to-market motion4 records

Distribution channels5 records

Marketing channels8 records

Osmind product offering

Product offering

Core offering

Osmind provides an AI-powered, psychiatry-tailored electronic health record (EHR) platform — Osmind One — purpose-built for interventional psychiatry practices delivering treatments such as TMS, ketamine, esketamine (SPRAVATO), and psychedelic-assisted therapies. Layered on Osmind One are Osmind Care Network (credentialing and payer-contract access), Osmind 360 (managed revenue cycle management and in-office infusion suite support), the Osmind Agent multimodal AI module, and a Life Sciences Solutions business that sells regulatory-grade real-world evidence derived from the network's 1.6B+ structured clinical variables to pharma, biotech, and medical device sponsors.

Product overview

Osmind operates a platform-plus-modules architecture anchored by its core psychiatric EHR, Osmind One, which unifies charting, scheduling, e-prescribing with PDMP access, lab ordering, telehealth, AI-powered workflows, and reporting for interventional psychiatry practices. Layered on top of Osmind One are the Osmind Agent autonomous AI module (multimodal sensing and workflow automation), the Osmind Care Network credentialing/referral product, and the Osmind 360 managed revenue cycle / billing service. Adjacent offerings include the Life Sciences real-world evidence platform (used with partners such as Compass Pathways, Cybin, and NRx Pharma) and content/community sub-brands (Psychiatry Collective and the Psychiatry Tomorrow Podcast) that support the same psychiatric practices served by the core platform.

Differentiator

Problem solved

Functional benefit

Brands

  • Osmind One: Psychiatry-tailored EHR software (formerly 'Original Osmind One') for practices billing cash or insurance on their own. Priced at $249/month per clinician.
  • Osmind Care Network
  • Osmind 360
  • Psychiatry Collective
  • Osmind Life Sciences

Products and services

  • Osmind One Osmind One is the company's flagship cloud-based electronic health record and practice management platform built specifically for interventional psychiatry practices. It bundles charting, scheduling, e-prescribing with PDMP access, lab ordering, HIPAA-compliant telehealth, AI-powered workflows, and reporting into a single product priced at $249/month per clinician.
  • Osmind Care Network Osmind Care Network is a curated network of interventional psychiatry practices combined with a credentialing, payer-contract, and implementation service designed to launch and scale insurance, SPRAVATO, TMS, and VNS programs for psychiatry practices.
  • Osmind 360 Osmind 360 is a managed billing, revenue cycle management, and in-office infusion suite service for psychiatric practices ready to scale, integrating directly with Osmind One to provide credentialing, insurance verification, claims submission, denial management, and buy-and-bill drug administration.
  • Osmind Agent Osmind Agent is a multimodal AI agent add-on module that combines continuous vitals monitoring, audio, video, and smartphone passive sensing to autonomously execute multi-step clinical and administrative workflows such as prior authorization submission and patient context surfacing.
  • Osmind Life Sciences Solutions Osmind Life Sciences Solutions is a B2B offering that leverages the Osmind One dataset (70,000+ patient dataset, 1.6B+ structured clinical variables) to deliver regulatory-grade real-world evidence for psychiatric drug development, supporting FDA submissions, Type C meetings, and commercial readiness partnerships.

Quantifiable outcome

  • 1M+ treatments delivered
  • +8 more outcomes

Companies that use Osmind

Customer profile

Named customers9 records

Segments4 records

Ideal customer profiles3 records

Osmind technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration11 records

AI capability12 records

Feature6 records

Osmind partnerships and signals

Strategic signal

Scale indicators12 records

Recent moves7 records

Expansion highlights7 records

Osmind competitors and assessment

Company assessment

Direct peers

  • TherapyNotes: TherapyNotes is a leading practice management and EHR platform built specifically for behavioral health providers, including psychiatrists, psychologists, and therapists. Like Osmind, it offers scheduling, documentation, billing, and a telehealth add-on, but serves a broader behavioral health base rather than interventional psychiatry specifically.
  • Valant: Valant is a behavioral health-specific EHR and practice management platform serving psychiatry and therapy practices. It is the most direct comparator to Osmind One in the psychiatric EHR category, with comparable charting, scheduling, e-prescribing, and billing workflows targeted at the same independent practice customer base.
  • SimplePractice: SimplePractice is an all-in-one practice management platform for health and wellness practitioners, including mental health providers. It overlaps with Osmind One on charting, scheduling, billing, and telehealth, but is positioned for solo and small group practices across many specialties rather than interventional psychiatry specifically.

Broad incumbents

  • athenahealth: athenahealth is a large, established EHR and practice management vendor serving ambulatory practices across many specialties. It is a broad incumbent that competes with Osmind One in the general EHR/practice management category, but does not specialize in interventional psychiatry workflows like REMS, buy-and-bill, or ketamine/SPRAVATO protocols.
  • Lyra Health: Lyra Health is a large mental health benefits platform serving employers with EAP, therapy, coaching, and psychiatric medication services. It overlaps with Osmind Care Network on the network/credentialing concept and competes for the same employer-sponsored mental health dollar, though Lyra delivers care directly while Osmind enables practices.
  • DrChrono (EverCommerce): DrChrono, part of EverCommerce's healthcare vertical, is a cloud-based EHR and medical billing platform serving ambulatory practices. It overlaps with Osmind on EHR and RCM but lacks the interventional psychiatry specialization, making it a partial competitor for general psychiatry practices.
  • Tebra (Kareo + PatientPop): Tebra is a practice management, EHR, and patient experience platform serving independent practices. Like Osmind, it bundles charting, scheduling, billing, and telehealth, but does not have purpose-built interventional psychiatry workflows and is positioned for general medical practices.

Regional players

  • Cerebral: Cerebral is a direct-to-consumer mental health platform offering telehealth psychiatry and therapy services, including medication management. While Cerebral delivers care (rather than selling software), it represents the vertically-integrated care model that Osmind could pursue and competes for the same interventional psychiatry patient population in the US.
  • Talkiatry: Talkiatry is a telepsychiatry practice group employing psychiatrists and delivering care directly to patients. It competes with Osmind-served independent practices for psychiatrists and patients, and represents an alternative vertically-integrated model for in-network psychiatric care in the US.

Emerging players

  • Headway: Headway is a managed network platform that connects mental health patients to in-network therapists and psychiatrists, handling credentialing, insurance billing, and payer contracts. It competes with Osmind Care Network's credentialing and payer contract value proposition, though Headway focuses on therapy rather than interventional psychiatry.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Osmind social profiles

Digital presence

Osmind compliance and trust

Trust signal

Compliance3 records

Osmind financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Osmind leadership team

Management profile

Number of profiles

Profiles9 records

Osmind subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Osmind funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors16 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Osmind M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Osmind

What does Osmind do?

Osmind provides an AI-powered, psychiatry-tailored electronic health record (EHR) platform — Osmind One — purpose-built for interventional psychiatry practices delivering treatments such as TMS, ketamine, esketamine (SPRAVATO), and psychedelic-assisted therapies. Layered on Osmind One are Osmind Care Network (credentialing and payer-contract access), Osmind 360 (managed revenue cycle management and in-office infusion suite support), the Osmind Agent multimodal AI module, and a Life Sciences Solutions business that sells regulatory-grade real-world evidence derived from the network's 1.6B+ structured clinical variables to pharma, biotech, and medical device sponsors.

Is Osmind a public or private company?

Osmind is a private company. It is classified as venture growth investor backed and is currently operating.

When was Osmind founded?

Osmind was founded in 2020. It employs 51 to 100 people.

Where is Osmind based?

Osmind is headquartered in San Francisco, United States, in the North America region.

How does Osmind make money?

Six revenue lines are on record. Osmind One EHR subscription is the primary driver. The others are osmind Care Network (RCM), osmind 360 (in-office drug infusion suite), life Sciences Solutions, implementation, credentialing, and processing fees and buy-and-bill drug margin.

Who are Osmind's main competitors?

Direct peers on record are TherapyNotes, Valant and SimplePractice. Broad incumbents are athenahealth, Lyra Health, DrChrono (EverCommerce) and Tebra (Kareo + PatientPop). Regional players are Cerebral and Talkiatry. Headway is listed as an emerging player.

Does Osmind have an API?

No public API is recorded for Osmind.

What industry is Osmind in?

Osmind's product category is Mental Health EHR Software. Its primary akta.pro industry code is HLALAEAB, Psychiatry & Medication Management Platforms. Its NAICS code is 5415 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BhbusinessEHR Designs Left Behavioral Health in the Dust. Will AI Help Leapfrog Traditional Issues?Behavioral health providers face EHR documentation barriers, with AI overlays emerging as a potential solution. Kindbridge plans an AI overlay to streamline processes, while Osmind offers a tailored psychiatry EHR. Providers caution against cookie-cutter AI notes and overutilized codes.BioSpaceTasman Therapeutics Announces Strategic Partnership with Osmind to Advance R-107 for Depressive DisordersTasman Therapeutics announced a multi-year strategic partnership with Osmind to support the development and commercialization of its investigational drug R-107 for treatment-resistant depression. The collaboration will leverage Osmind's real-world evidence platform and clinical network to optimize Tasman's pivotal Phase 3 ROCKET program and prepare for potential future launch. Topline data for the Phase 3 trial is anticipated in 2027.PR NewswireTasman Therapeutics Announces Strategic Partnership with Osmind to Advance R-107 for Depressive DisordersTasman Therapeutics announced a multi-year partnership with Osmind to support its R-107 ketamine Phase 3 trial and future commercialization. The collaboration will leverage Osmind's real-world data and clinical network for trial design and site identification. R-107 is an oral extended-release ketamine for treatment-resistant depression, with topline data expected in 2027.EIN PresswireHealth Policy Podcast Episode Examines Human and Economic Toll of Treatment-Resistant DepressionA Health Policy Podcast episode features Mark Desmarais and Dr. William Sauvé discussing treatment-resistant depression's impact on Medicare. They report TRD patients incur about $8,000 more in annual healthcare costs and cite prior authorization delays as a barrier. Both guests call for policy pathways to improve access to effective treatments.Investing.comStudy finds IV ketamine shows higher remission rates than esketamine By Investing.comNRx Pharmaceuticals announced at the 2026 American Society of Clinical Psychopharmacology annual conference the presentation of a study comparing treatment outcomes for intravenous ketamine and intranasal esketamine in patients with treatment-resistant depression. The study, conducted by Osmind Inc. in collaboration with Yale University, analyzed electronic health records from 10,054 patients across 800 community psychiatry clinics and found that IV ketamine patients achieved 34% remission and 63% response rates compared to 26% remission and 58% response for esketamine patients, with statistical significance. The authors noted the primary limitation that treatment assignments were not randomized, and unmeasured confounding variables may have contributed to outcome differences.Stock TitanNRx Pharma: IV ketamine outperforms nasal esketamineNRx Pharmaceuticals announced the presentation of a peer-reviewed study at the 2026 American Society of Clinical Psychopharmacology conference, in which Osmind, Inc. compared IV ketamine treatment (8,224 patients) to intranasal esketamine (1,830 patients) for treatment-resistant depression. The study found IV ketamine patients achieved 34% remission and 63% response rates versus 26% remission and 58% response for intranasal esketamine, representing approximately 50% higher odds of remission (OR 1.51, P<.001) and 22% higher odds of response (OR 1.22, P<.003).Investing.comFDA grants priority voucher to Compass for psilocybin treatment By Investing.comThe FDA granted Compass Pathways plc selection for the Commissioner's National Priority Voucher program and a rolling New Drug Application review for its COMP360 synthetic psilocybin treatment targeting treatment-resistant depression. The treatment demonstrated statistically significant results in two Phase 3 clinical trials involving over 1,000 participants, with a generally well-tolerated safety profile, potentially addressing an unmet need for approximately 4 million U.S. patients. Analyst coverage initiated with Buy ratings of $14-$17, and a collaboration with Osmind for clinic preparation underscores strategic efforts toward potential regulatory approval and commercial launch.Business Wire BlogCompass Pathways Collaborates with Osmind to Advance Independent Clinic Readiness for Psychedelic TreatmentsCompass Pathways plc announced a collaboration with Osmind, a public benefit corporation operating a network of over 1,000 interventional psychiatry practices, to inform how small-to-medium sized clinics can effectively deliver psychedelic treatments if FDA approved. The partnership aims to understand the operational, clinical, and infrastructure needs of independent psychiatry practices and develop scalable care models for potential delivery of COMP360 psilocybin treatment. This collaboration expands Compass's existing set of partnerships designed to prepare various care settings for the potential future launch of its investigational therapy.Stock TitanCompass Pathways partners with Osmind on clinic readinessCompass Pathways announced a collaboration with Osmind to help small-to-medium sized independent clinics prepare for the potential future delivery of psychedelic treatments, specifically its investigational COMP360 psilocybin treatment if FDA approved. The partnership aims to understand the operational, clinical, and infrastructure needs of independent psychiatry practices and develop scalable care models. Osmind's network comprises over 1,000 clinics, representing one of the largest networks of interventional psychiatry practices in the United States.GurufocusCompass Pathways (CMPS) Partners with Osmind for Psychedelic TreOn April 21, 2026, Compass Pathways announced a partnership with Osmind to help small and medium-sized clinics effectively administer psychedelic therapies, pending FDA approval. The collaboration aims to broaden accessibility of COMP360, Compass's proprietary synthetic psilocybin treatment for mental health conditions including treatment-resistant depression. Compass Pathways is a biotechnology company with a market capitalization of approximately $1.27 billion focused on developing innovative mental health therapies.